StockData
FitLife Brands, Inc. logo

FitLife Brands, Inc. (FTLF) stock

FTLFNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/301% below fair value
$6.89+0.06 (+0.88%)

Close on Nov 18, 2026Market cap $64.70MP/E 36.3Yield –

FitLife Brands free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

FitLife Brands's free cash flow for the twelve months ending Jun 30, 2026 was $10.02M. For fiscal 2025 it was $7.40M, down 22.9% from the year before. The highest annual figure on record is $9.60M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.40M-22.9%
FY2024Dec 31, 2024$9.60M+133.3%
FY2023Dec 31, 2023$4.11M-0.4%
FY2022Dec 31, 2022$4.13M+1500.8%
FY2018Dec 31, 2018$258.00K-46.4%
FY2017Dec 31, 2017$481.00K+1842.3%
FY2016Dec 31, 2016$24.76K–
FY2015Dec 31, 2015-$2.47M-264.2%
FY2014Dec 31, 2014$1.50M+1305.9%
FY2011Dec 31, 2011$106.91K–
FY2010Dec 31, 2010-$1.87M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.64M+279.8%
Q1 FY2026Mar 31, 2026$2.48M+21.3%
Q4 FY2025Dec 31, 2025$239.00K-84.8%
Q3 FY2025Sep 30, 2025$3.66M-27.1%
Q4 FY2024Dec 31, 2024$957.00K-31.7%
Q3 FY2024Sep 30, 2024$2.05M+110.6%
Q2 FY2024Jun 30, 2024$1.57M+4.1%
Q1 FY2024Mar 31, 2024$5.03M+2066.4%
Q4 FY2023Dec 31, 2023$1.40M–
Q3 FY2023Sep 30, 2023$972.00K-63.0%
Q2 FY2023Jun 30, 2023$1.51M+161.8%
Q1 FY2023Mar 31, 2023$232.00K-8.3%
Q4 FY2022Dec 31, 2022-$873.00K–
Q3 FY2022Sep 30, 2022$2.63M+501.3%
Q4 FY2018Dec 31, 2018$576.00K–
Q4 FY2017Dec 31, 2017$253.00K–
Q3 FY2017Sep 30, 2017-$186.00K-202.7%
Q2 FY2017Jun 30, 2017$436.57K-68.1%
Q1 FY2017Mar 31, 2017-$22.57K–
Q4 FY2016Dec 31, 2016-$311.28K–
Q3 FY2016Sep 30, 2016$181.06K–
Q2 FY2016Jun 30, 2016$1.37M–

More FitLife Brands figures

See a number that looks wrong?